Literature DB >> 9517621

Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?

F Santamaria1, G Parenti, G Guidi, M Filocamo, P Strisciuglio, G Grillo, V Farina, P Sarnelli, M G Rizzolo, A Rotondo, G Andria.   

Abstract

Pulmonary disease is a complication of Gaucher disease (GD), a lysosomal disorder due to the deficiency of glucocerebrosidase. Lung involvement was investigated through chest radiography, high-resolution computed tomography of the chest, pulmonary function tests (PFT), and oxygen saturation (SaO2) at 21% FI(O2) in 13 Italian GD patients, six homoallelic for the L444P mutation (Group A), seven with various genotypes (Group B). Echocardiography and transcutaneous oxygen tension measurement at room air and after breathing 100% oxygen were performed to exclude pulmonary hypertension and/or intrapulmonary shunts. A score index (SI) including lung involvement evaluated the severity of GD. In three Group A patients with respiratory symptoms and in an asymptomatic male interstitial involvement was demonstrated; one child died of aspiration pneumonia. Group B patients had no signs of lung damage; PFT were normal in all cases but one. SaO2 was normal in both groups. Pulmonary vascular disease was ruled out in three cases with respiratory symptoms. In Groups A and B the median SI were 22 and 13, respectively (p < 0.01). L444P homozygotes appear at major risk for developing pulmonary disease, even at earlier ages. A comprehensive evaluation of lung involvement is recommended primarily in these subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517621     DOI: 10.1164/ajrccm.157.3.9706057

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

2.  Allogeneic hematopoietic stem cell transplantation for treating severe lung involvement in Gaucher disease.

Authors:  Fu-Shiuan Lee; Hsiu-Ju Yen; Dau-Ming Niu; Giun-Yi Hung; Chih-Ying Lee; Yi-Chen Yeh; Paul Chih-Hsueh Chen; Sheng-Kai Chang; Chia-Feng Yang
Journal:  Mol Genet Metab Rep       Date:  2020-10-20

3.  Assessment of Basal Metabolic Rate and Nutritional Status in Patients with Gaucher Disease Type III.

Authors:  Divair Doneda; Filippo P Vairo; André L Lopes; Alvaro Reischak-Oliveira; Pedro Schestatsky; Marino M Bianchin; Cileide C Moulin; Ida V D Schwartz
Journal:  JIMD Rep       Date:  2013-12-17

Review 4.  The future is here: Integrating genetics into the pediatric pulmonary clinic.

Authors:  Megan H Hawley; Peter P Moschovis; Mengdi Lu; T Bernard Kinane; Lael M Yonker
Journal:  Pediatr Pulmonol       Date:  2020-07

5.  A case of galactosemia misdiagnosed as cow's milk intolerance.

Authors:  Roberto Della Casa; Carla Ungaro; Emma Acampora; Claudio Pignata; Pietro Vajro; Mariacarolina Salerno; Francesca Santamaria; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2012-09-19       Impact factor: 2.638

Review 6.  A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.

Authors:  Jérôme Stirnemann; Nadia Belmatoug; Fabrice Camou; Christine Serratrice; Roseline Froissart; Catherine Caillaud; Thierry Levade; Leonardo Astudillo; Jacques Serratrice; Anaïs Brassier; Christian Rose; Thierry Billette de Villemeur; Marc G Berger
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

7.  Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy.

Authors:  Amal El Beshlawy; Vagishwari Murugesan; Pramod Kumar Mistry; Khaled Eid
Journal:  Mol Genet Metab Rep       Date:  2019-06-28

8.  Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study).

Authors:  Cecilia Lazea; Simona Bucerzan; Camelia Al-Khzouz; Anca Zimmermann; Ștefan Cristian Vesa; Ioana Nașcu; Victoria Creț; Mirela Crișan; Carmen Asăvoaie; Diana Miclea; Paula Grigorescu-Sido
Journal:  Diagnostics (Basel)       Date:  2021-05-29

9.  Hypertransaminasemia and fatal lung disease: a case report.

Authors:  Francesca Santamaria; Sara De Stefano; Silvia Montella; Marco Maglione; Roberto Della Casa; Emma Acampora; Claudio Pignata; Mariacarolina Salerno; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2013-02-07       Impact factor: 2.638

10.  Lung lysed: A case of Gaucher disease with pulmonary involvement.

Authors:  Poonam Sherwani; Adweta Vire; Rama Anand; Ruchika Gupta
Journal:  Lung India       Date:  2016 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.